COPD (chronic obstructive pulmonary disease) clinical trials

Medical name: Chronic obstructive pulmonary disease · Lungs & breathing

675 trials are recruiting, according to ClinicalTrials.gov.

Showing 100 of 675, newest first. Checked against the registry on 22 November 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.

Not yet recruiting · Not applicable

Developing an Intervention to Optimize Virtual Care Adoption for COPD Management

Ages 40 Years to no maximum · 2 sites · VA Office of Research and Development

NCT05986214 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support

Ages 40 Years to 80 Years · 4 sites · Sir Run Run Shaw Hospital

NCT07751003 on ClinicalTrials.gov

Not yet recruiting · Phase 4

RSV Vaccination to Reduce Recurrent AECOPD

Ages 50 Years to no maximum · 1 site · Chinese University of Hong Kong

NCT07508644 on ClinicalTrials.gov

Not yet recruiting · Phase 1 / Phase 2

cfMSC Stem Cell Therapy Targeting COPD

Ages 40 Years to 80 Years · 1 site · Shenzhen Geno-Immune Medical Institute

NCT07477600 on ClinicalTrials.gov

Not yet recruiting · Phase 3

The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease

Ages 40 Years to no maximum · 26 sites · Boehringer Ingelheim

NCT07907991 on ClinicalTrials.gov

Not yet recruiting · Phase 2 / Phase 3

An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

Ages 18 Years to no maximum · 15 sites · United Therapeutics

NCT07923526 on ClinicalTrials.gov

Not yet recruiting · Phase 1

Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations

Ages 65 Years to no maximum · 1 site · Duke University

NCT07275359 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype

Ages 40 Years to no maximum · 0 sites · Sidra Aziz

NCT07795086 on ClinicalTrials.gov

Not yet recruiting · Phase 3

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

Ages 40 Years to no maximum · 1 site · Eurofarma Laboratorios S.A.

NCT06234345 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

Ages No minimum to 80 Years · 0 sites · CSA Medical, Inc.

NCT07468617 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Utility of Respiratory Biomarker Guidance in Exacerbations

Ages 18 Years to no maximum · 1 site · Université de Sherbrooke

NCT07942298 on ClinicalTrials.gov

Not yet recruiting · Not applicable

A Study of the Effect of a Nurse Navigator Program on High Risk Patients

Ages 18 Years to no maximum · 1 site · Mayo Clinic

NCT05592847 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Sustainable Inhaler Prescribing in Intermediate Care Units

Ages 18 Years to no maximum · 1 site · Consorci Sanitari de l'Alt Penedès i Garraf

NCT07933913 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Pulmonary Rehabilitation Frequency in COPD Patients

Ages No minimum to no maximum · 0 sites · Hospital Universitario Fundación Alcorcón

NCT07575841 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Pulmonary Rehabilitation in African Countries

Ages 18 Years to no maximum · 3 sites · University of Edinburgh

NCT07602673 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Construction and Validation of a Clinical Cohort on the Pathogenesis Evolution and Syndrome-Differentiated Treatment of Chronic Obstructive Pulmonary Disease Based on Core Targets of Airway Inflammation and Remodeling

Ages 40 Years to no maximum · 4 sites · First Affiliated Hospital of Ningbo University

NCT07944157 on ClinicalTrials.gov

Not yet recruiting · Phase 1 / Phase 2

The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD

Ages 18 Years to 85 Years · 0 sites · University of Alberta

NCT04231760 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Assessment of Upper Airway Patency

Ages 18 Years to no maximum · 1 site · Fisher and Paykel Healthcare

NCT07949812 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Portable Positive Pressure Therapy Device

Ages 21 Years to 85 Years · 0 sites · Koronis Biomedical Technologies

NCT04452851 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Effect on Bronchodilation Response and Ventilation Heterogeneity of Different Inhalation Volumes in COPD

Ages 40 Years to no maximum · 1 site · University of Milan

NCT05381415 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Effect of add-on Doxofylline on Lung Function in Stable COPD

Ages 40 Years to no maximum · 1 site · University of Milan

NCT04238221 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Effectiveness and Efficiency of Home Telemonitoring and Non-invasive Ventilation in Patients With COPD and Hypercapnia (EVALECO)

Ages 50 Years to 90 Years · 1 site · Air Liquide Healthcare Spain

NCT07679646 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Performance of Lumetry for Arterial Carbon Dioxide (paCO2) Assessment and Chronic Obstructive Pulmonary Disease (COPD) Screening

Ages 18 Years to 90 Years · 1 site · Lumetry Diagnostics GmbH

NCT07951281 on ClinicalTrials.gov

Recruiting · Not applicable

Reducing Exposure With Air Cleaners and Technology

Ages 13 Years to no maximum · 3 sites · University of California, Berkeley

NCT07914010 on ClinicalTrials.gov

Not yet recruiting · Not applicable

The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.

Ages 18 Years to 75 Years · 3 sites · University Hospital, Bordeaux

NCT07923656 on ClinicalTrials.gov

Recruiting · Not applicable

Digital Inhaler Use in Obstructive Lung Disease Care

Ages 18 Years to no maximum · 1 site · Cedars-Sinai Medical Center

NCT07214337 on ClinicalTrials.gov

Not yet recruiting · Not applicable

High-Intensity Interval Alternating Concentric-Eccentric Training in Chronic Respiratory Disease

Ages 18 Years to no maximum · 1 site · Fu Jen Catholic University Hospital

NCT07867535 on ClinicalTrials.gov

Recruiting · Phase 3

Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)

Ages 40 Years to 80 Years · 7 sites · Merck Sharp & Dohme LLC

NCT07874815 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Home-based Pulmonary Rehabilitation for COPD Patients

Ages 40 Years to 100 Years · 1 site · Karolinska Institutet

NCT04820257 on ClinicalTrials.gov

Recruiting · Not applicable

Effectiveness of Active Cycle of Breathing Techniques in Patients With Chronic Obstructive Pulmonary Disease

Ages 40 Years to 90 Years · 1 site · National Yang Ming Chiao Tung University Hospital

NCT07818187 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease

Ages 18 Years to no maximum · 1 site · Jacob Sandberg

NCT07836764 on ClinicalTrials.gov

Not yet recruiting · Not applicable

EFFECT OF COMBINED VIRTUAL REALITY-GUIDED BREATHING AND AEROBIC TRAINING ON VENTILATORY FUNCTION IN PATIENTS WITH COPD

Ages 45 Years to 55 Years · 0 sites · Cairo University

NCT07885995 on ClinicalTrials.gov

Recruiting · Phase 2

Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients

Ages 40 Years to 75 Years · 2 sites · AeroRx Therapeutics Inc.

NCT07896252 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

Ages 18 Years to no maximum · 16 sites · United Therapeutics

NCT07923591 on ClinicalTrials.gov

Recruiting · Not applicable

Chronic Respiratory Disease Participant Engagement Study

Ages 18 Years to no maximum · 1 site · Richmond Research Institute

NCT07924462 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Acute Muscular and Vascular Responses to a Single Session of Exercise With BFR in COPD

Ages 45 Years to no maximum · 1 site · University Hospital, Grenoble

NCT07668921 on ClinicalTrials.gov

Not yet recruiting · Phase 1

A Study of RSS0343 Tablets in Healthy Participants and in Participants With Mild or Moderate Renal Impairment

Ages 18 Years to 65 Years · 1 site · Reistone Biopharma Company Limited

NCT07940829 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Effect of Dietary Fiber Supplementation on Systemic Inflammation and Clinical Parameters in COPD

Ages 18 Years to 75 Years · 1 site · Júnea Regina Pires Drews

NCT07868211 on ClinicalTrials.gov

Recruiting · Not applicable

Multimodal Assessment of Neuromuscular Electrical Stimulation (NMES) Effects on Respiratory and Peripheral Muscles in Chronic Obstructive Pulmonary Disease (COPD)

Ages 40 Years to no maximum · 1 site · Universitas Padjadjaran

NCT07910006 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.

Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nīmes

NCT07907601 on ClinicalTrials.gov

Not yet recruiting · Not applicable

COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease

Ages 18 Years to no maximum · 0 sites · VASCage GmbH

NCT07856667 on ClinicalTrials.gov

Not yet recruiting · Phase 2

Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD

Ages 40 Years to no maximum · 0 sites · Bryan A. Ross

NCT07871357 on ClinicalTrials.gov

Recruiting · Phase 2

A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Ages 40 Years to 80 Years · 10 sites · GlaxoSmithKline

NCT07915791 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)

Ages 18 Years to 65 Years · 1 site · National Institute of Allergy and Infectious Diseases (NIAID)

NCT07867184 on ClinicalTrials.gov

Recruiting · Not applicable

Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise

Ages 18 Years to 75 Years · 1 site · Johns Hopkins University

NCT07686302 on ClinicalTrials.gov

Recruiting · Phase 1 / Phase 2

A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Ages 18 Years to 80 Years · 1 site · Hoffmann-La Roche

NCT07822334 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD

Ages 18 Years to 90 Years · 1 site · Capital Development Authority (CDA)

NCT07708337 on ClinicalTrials.gov

Recruiting · Phase 2 / Phase 3

A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease

Ages 18 Years to no maximum · 4 sites · Enanta Pharmaceuticals, Inc

NCT07908381 on ClinicalTrials.gov

Not yet recruiting · Not applicable

RESP-FIT: A Respiratory Muscle Strength Training Intervention for COPD

Ages 40 Years to no maximum · 0 sites · Medical University of South Carolina

NCT07811219 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Long-term Effects and Maintenance of Exercise Habits in Individuals With COPD

Ages 40 Years to 80 Years · 1 site · Copenhagen University Hospital, Rigshospitalet

NCT07870655 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Impact of Nurse-Led Pulmonary Rehabilitation on Dyspnea, Fatigue and Self-Efficacy in COPD Patients

Ages 40 Years to no maximum · 0 sites · University of Health Sciences Lahore

NCT07913334 on ClinicalTrials.gov

Recruiting · Not applicable

Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over Trial

Ages 18 Years to no maximum · 1 site · Fondation Hôpital Saint-Joseph

NCT06811402 on ClinicalTrials.gov

Recruiting · Phase 3

A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time

Ages 35 Years to 80 Years · 3 sites · Pfizer

NCT07839884 on ClinicalTrials.gov

Recruiting · Not applicable

THERMotherapy Against Persistent Bacterial LUNG Infections

Ages 18 Years to no maximum · 1 site · Chronic Obstructive Pulmonary Disease Trial Network, Denmark

NCT05351242 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Indoor Overheating and Physiological Strain in Older Adults With COPD

Ages 60 Years to 80 Years · 1 site · University of Ottawa

NCT07852910 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients

Ages 40 Years to no maximum · 1 site · Akdeniz University

NCT07581132 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS

Ages 40 Years to 74 Years · 1 site · Istinye University

NCT07185178 on ClinicalTrials.gov

Recruiting · Phase 4

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization

Ages 40 Years to no maximum · 1 site · Regeneron Pharmaceuticals

NCT07587658 on ClinicalTrials.gov

Recruiting · Not applicable

Effects of TPB-Based Cadence Exercise and Breathing Training on Physiological Parameters and Quality of Life in Patients With COPD

Ages 40 Years to no maximum · 2 sites · Fu Jen Catholic University Hospital

NCT07860008 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Multi-Omics Study of COPD Stages and Traditional Chinese Medicine Syndromes

Ages 35 Years to no maximum · 0 sites · Guangzhou Institute of Respiratory Disease

NCT07873489 on ClinicalTrials.gov

Not yet recruiting · Not applicable

The Impact of Indoor Environmental Quality on Symptoms in Patients With Chronic Obstructive Pulmonary Disease

Ages 18 Years to no maximum · 1 site · Ziekenhuis Oost-Limburg

NCT07799896 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Improving Medication Management in COPD

Ages 45 Years to no maximum · 0 sites · Duke University

NCT07453719 on ClinicalTrials.gov

Not yet recruiting · Phase 4

Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab

Ages 55 Years to 85 Years · 0 sites · Western University, Canada

NCT07749001 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High Flow: An MRI Study

Ages 18 Years to no maximum · 1 site · Klinikum Dortmund Wirbelsäulenchirurgie

NCT07886502 on ClinicalTrials.gov

Not yet recruiting · Phase 1 / Phase 2

A Study to Investigate Small Mobile Stem Cells (SMS) in Moderate to Severe Chronic Obstructive Pulmonary Disease

Ages 18 Years to no maximum · 1 site · SMSbiotech

NCT07871890 on ClinicalTrials.gov

Recruiting · Not applicable

PBMT Associated With a Pulmonary Rehabilitation Program on the Functional Capacity of Patients With COPD

Ages 18 Years to 90 Years · 1 site · Federal University of Health Science of Porto Alegre

NCT07878884 on ClinicalTrials.gov

Recruiting · Not applicable

Primary Palliative Care - a Feasibility Cluster Trial

Ages 18 Years to no maximum · 1 site · University of Coimbra

NCT07737899 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Nutritional Risk and Diaphragmatic Thickness in Mechanically Ventilated COPD Patients

Ages 60 Years to no maximum · 0 sites · Assiut University

NCT07788170 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation

Ages 18 Years to no maximum · 1 site · University of Leicester

NCT07500948 on ClinicalTrials.gov

Not yet recruiting · Phase 3

A Clinical Study of REGEND001 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Ages 40 Years to 75 Years · 1 site · Regend Therapeutics

NCT07828353 on ClinicalTrials.gov

Recruiting · Not applicable

RESET-COPD Cohort: Real-Time Monitoring and Early Warning in COPD Patients Receiving Home NPPV

Ages 18 Years to no maximum · 1 site · Beijing Chao Yang Hospital

NCT07701096 on ClinicalTrials.gov

Recruiting · Not applicable

Comparison of Arterial and Capillary Blood Gas Analyses in Patients With Respiratory Distress Due to COPD or APE

Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nice

NCT07835945 on ClinicalTrials.gov

Not yet recruiting · Not applicable

The CANadian EXAcerbation of COPD Trial

Ages 40 Years to no maximum · 1 site · McGill University Health Centre/Research Institute of the McGill University Health Centre

NCT07850648 on ClinicalTrials.gov

Recruiting · Not applicable

BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA

Ages No minimum to no maximum · 10 sites · AstraZeneca

NCT07570394 on ClinicalTrials.gov

Enrolling by invitation · Phase 3

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

Ages 40 Years to 80 Years · 16 sites · Sanofi

NCT07793409 on ClinicalTrials.gov

Recruiting · Not applicable

A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD

Ages 18 Years to 110 Years · 1 site · Liverpool Heart and Chest Hospital NHS Foundation Trust

NCT07253883 on ClinicalTrials.gov

Recruiting · Phase 3

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Ages 40 Years to 80 Years · 9 sites · GlaxoSmithKline

NCT07780656 on ClinicalTrials.gov

Enrolling by invitation · Not applicable

Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

Ages 18 Years to 85 Years · 1 site · State University of New York at Buffalo

NCT07512687 on ClinicalTrials.gov

Recruiting · Not applicable

Comparing Advanced Technologies to Standard Testing for the Diagnosis of Airway Disease in Hospital and Community Settings

Ages 18 Years to no maximum · 2 sites · University Hospital Southampton NHS Foundation Trust

NCT07798596 on ClinicalTrials.gov

Not yet recruiting · Phase 1

A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

Ages 40 Years to 82 Years · 0 sites · Rise Therapeutics LLC

NCT07076290 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Cross-Regional Unmanned Aircraft Transport of Donor Lungs

Ages 18 Years to no maximum · 1 site · The First Affiliated Hospital of Guangzhou Medical University

NCT07790822 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Evaluation of the Benefits of Hypnosis in Improving the Quality of Life of Patients With Chronic Obstructive Pulmonary Disease (COPD) Suffering From Persistent Dyspnea

Ages 18 Years to no maximum · 1 site · Assistance Publique - Hôpitaux de Paris

NCT07637604 on ClinicalTrials.gov

Not yet recruiting · Not applicable

ECHO-COPD: Impact of a Pharmacist-Led Health Belief Model-Based Educational Intervention Among Chronic Obstructive Pulmonary Disease Patients

Ages 18 Years to 65 Years · 1 site · Rabia Hussain

NCT07815353 on ClinicalTrials.gov

Not yet recruiting · Not applicable

New Diagnostic Approaches in the Management of Inflammatory Lung Diseases

Ages 18 Years to no maximum · 0 sites · Fondazione Don Carlo Gnocchi ETS

NCT07723638 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE

Ages 1 Year to 80 Years · 1 site · University Hospital, Bordeaux

NCT07780630 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD

Ages 18 Years to no maximum · 1 site · ADIR Association

NCT07747571 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Dynamic Changes in Right Ventricle and Pulmonary Artery Coupling Among COPD Patients With Acute Exacerbation

Ages 40 Years to no maximum · 1 site · Assiut University

NCT07694713 on ClinicalTrials.gov

Not yet recruiting · Not applicable

FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease

Ages 18 Years to no maximum · 1 site · Aveiro University

NCT07792642 on ClinicalTrials.gov

Not yet recruiting · Not applicable

HFNC During Bronchoscopy in COPD Patients

Ages 18 Years to no maximum · 0 sites · The First Affiliated Hospital of Guangzhou Medical University

NCT07850856 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Time Course of Respiratory Oscillometry Parameters During Nasal High-Flow Therapy in Stable Chronic Obstructive Pulmonary Disease

Ages 18 Years to 85 Years · 1 site · ADIR Association

NCT07750613 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Immuno-inflammatory Response of Erdosteine in COPD

Ages 45 Years to no maximum · 1 site · Pierachille Santus, MD, PhD

NCT07329946 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Impact of Combined Cardio-pulmonary Assessment on COPD Clinical Management.

Ages 41 Years to no maximum · 0 sites · University of Bari Aldo Moro

NCT07481825 on ClinicalTrials.gov

Not yet recruiting · Not applicable

EFFECTIVENESS OF COMBINED CONCENTRIC AND ECCENTRIC AEROBIC EXERCISE ON A TREADMILL IN PATIENTS WITH COPD: A RANDOMIZED CLINICAL TRIAL.

Ages 18 Years to no maximum · 1 site · Universidad Europea de Madrid

NCT07627035 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Extracorporeal Carbon Dioxide Removal Plus Noninvasive Ventilation in Patients With COPD Not Eligible for Intubation

Ages 18 Years to no maximum · 1 site · Hospital del Mar Research Institute (IMIM)

NCT07785375 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD

Ages 45 Years to 75 Years · 1 site · University of Nebraska

NCT07703527 on ClinicalTrials.gov

Not yet recruiting · Not applicable

Muscle Oxygenation in Patients With COPD Exacerbation

Ages 40 Years to no maximum · 1 site · Hacettepe University

NCT07801547 on ClinicalTrials.gov

Not yet recruiting · Not applicable

High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease

Ages 18 Years to no maximum · 1 site · Zhejiang University

NCT07791979 on ClinicalTrials.gov

Not yet recruiting · Not applicable

The Effect of Pranayama Practiced With Rain Sounds on Self-Efficacy, Dyspnea, and Respiratory Functions in Patients With COPD

Ages 18 Years to no maximum · 0 sites · Inonu University

NCT07820059 on ClinicalTrials.gov

Not yet recruiting · Phase 2

GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

Ages 40 Years to 80 Years · 1 site · The Cleveland Clinic

NCT07747805 on ClinicalTrials.gov

More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · Depression clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials · Osteoporosis clinical trials · Rett syndrome clinical trials